Cutia Therapeutics' Enrolled Patients Completes Phase II Clinical Trial for Metabolic Disease Drug
Cutia Therapeutics' Enrolled Patients Completes Phase II Clinical Trial for Metabolic Disease Drug
Cutia Therapeutics入组患者完成了代谢性疾病药物的II期临床试验
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册